Latest Breaking News On - Pharmaceuticals company profile - Page 8 : comparemela.com

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 6 5%

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 6 5%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPharmaceuticals dailyCantor fitzgeraldEuclidean capitalAlkeon capital managementPharmaceuticals company profileAlgert globalPharmaceuticals stockPharmaceuticals incJump financialJpmorgan chase coVivo capitalGet free reportCapital management

ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Up 6 5%

ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Up 6 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesOric pharmaceuticals incCantor fitzgeraldPharmaceuticals dailyAlgert globalAlkeon capital managementPharmaceuticals company profileEuclidean capitalPharmaceuticals stockVivo capitalJpmorgan chase coJump financialPharmaceuticals incGet free reportCapital management

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) CEO Stephen Davis Sells 11,427 Shares

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the transaction, the chief executive officer now owns 155,231 shares of the company’s […]

Sakhalinskaya oblastUnited statesRobertw bairdStephen davisPharmaceuticals price performancePharmaceuticals company profilePharmaceuticals dailyNorges bankEventide asset managementAcadia pharmaceuticals incPharmaceuticals incMg investment management ltdRoyal bankFred alger managementGet free reportAlger management

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) CEO Stephen Davis Sells 11,427 Shares of Stock

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the sale, the chief executive officer now directly owns 155,231 shares of the […]

United statesStephen davisPhocas financial corpEmpire life investments incRoyal bankPharmaceuticals incPharmaceuticals stock downPharmaceuticals company profileQuest partnersMorgan stanleyCantor fitzgeraldFranklin resources incAcadia pharmaceuticals incPharmaceuticals dailyGet free reportStock down

X4 Pharmaceuticals (NASDAQ:XFOR) Price Target Increased to $5 00 by Analysts at HC Wainwright

X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) had its target price lifted by equities researchers at HC Wainwright from $3.00 to $5.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 352.49% from the company’s […]

Paula raganAdams mostafaSecurities exchange commissionPharmaceuticals stock performanceCapital partnersPharmaceuticals company profilePharmaceuticals dailyStonepine capital managementPharmaceuticals incBain capital life sciences investorsSg americas securitiesGet free reportExchange commissionCapital life sciences investorsCapital managementX4 pharmaceuticals